CalciMedica, Inc. cotiza a 1.12 USD y tiene una capitalización bursátil de $8M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitor…
| Periodo | 2026-08 | 2026-05 | 2026-03 | 2025-11 |
|---|---|---|---|---|
| Real | $-2.25 | $1.50 | $-3.45 | $-2.60 |
| Estimado | $-1.45 | $-1.40 | $-2.06 | $-2.06 |
| Sorpresa | -55.2% | +207.1% | -67.5% | -26.2% |
| Métrica | CALC | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | — | -40.4% | — |
| ROA | -217.5% | -32.0% | -185.5% |
| Current Ratio | 3.58 | 2.84 | +0.74 |
| Debt / Equity | — | 0.28 | — |